FindTrial
Sign In

FDG-Positron Emission Tomography and Computed Tomography Scan

PROCEDURE3 trials

Sponsors

National Cancer Institute (NCI), Roswell Park Cancer Institute

Conditions

Extensive-stage Small-cell Lung CancerGanglioneuroblastoma, NodularLimited-stage Small-cell Lung CancerLung Non-Small Cell CarcinomaNeuroblastomaRecurrent Langerhans Cell HistiocytosisRefractory Langerhans Cell HistiocytosisStage IIIA Lung Cancer

Phase 1

An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer
WithdrawnNCT06427369
Roswell Park Cancer InstituteExtensive-stage Small-cell Lung Cancer, Limited-stage Small-cell Lung Cancer, Lung Non-Small Cell Carcinoma +2
Start: 2024-10-01End: 2027-09-01Updated: 2024-09-27

Phase 2

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
RecruitingNCT05828069
National Cancer Institute (NCI)Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Start: 2024-03-28End: 2028-09-30Target: 48Updated: 2026-04-03

Phase 3

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingNCT06172296
National Cancer Institute (NCI)Ganglioneuroblastoma, Nodular, Neuroblastoma
Start: 2024-04-19End: 2029-12-31Target: 478Updated: 2026-04-03